Zoledronic acid for the prevention of bone metastases in high risk prostate cancer patients: a randomized, open label, multicentre study of the European Association of Urology (EAU) in cooperation with the Scandinavian prostate cancer group (SPCG) and the Arbeitsgemeinschaft Urologische Onkologie (AUO)

Tammela, T. (Contributor)

Activity: Talk or presentation › Conference presentation

Description

Contributors: Wirth M, Tammela T, Huland H, Cicalese V, Gomez Veiga F, Delaere K, Schulze M, Bartsch G, Debruyne F, Miller K, Patel A, Torri V, Tubaro A, Witjes W

Period	28 Mar 2008
Event title	23rd Annual EAU Congress, Milan, 26-29 March 2008
Event type	Other
Degree of Recognition	International

Documents & Links

http://www.eaumilan2008.org/